SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 258 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,216,000 | -50.2% | 8,000 | -61.0% | 0.08% | -65.3% |
| Q1 2019 | $2,443,000 | +9.2% | 20,500 | 0.0% | 0.24% | -47.9% |
| Q4 2018 | $2,237,000 | -32.4% | 20,500 | 0.0% | 0.45% | +105.9% |
| Q3 2018 | $3,311,000 | -9.6% | 20,500 | -26.0% | 0.22% | -32.9% |
| Q2 2018 | $3,664,000 | +59.4% | 27,720 | -10.6% | 0.33% | +47.7% |
| Q1 2018 | $2,298,000 | -6.6% | 31,020 | -29.9% | 0.22% | -7.9% |
| Q4 2017 | $2,460,000 | +16.6% | 44,220 | -4.9% | 0.24% | -45.7% |
| Q3 2017 | $2,110,000 | -1.0% | 46,520 | -26.4% | 0.44% | -15.6% |
| Q2 2017 | $2,131,000 | +207.9% | 63,220 | +170.5% | 0.53% | +154.1% |
| Q1 2017 | $692,000 | -58.0% | 23,370 | -61.0% | 0.21% | -84.2% |
| Q4 2016 | $1,646,000 | -83.2% | 60,000 | -62.5% | 1.31% | -65.8% |
| Q3 2016 | $9,826,000 | +348.1% | 160,000 | +39.1% | 3.84% | +307.8% |
| Q2 2016 | $2,193,000 | – | 115,000 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |